Quoin Pharmaceuticals, Ltd. (QNRX)

CIK 1671502 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Quoin Pharmaceuticals, Ltd..

Recent SEC filings

FiledFormAccession number
Sep 10, 2026D0001104659-26-106751
Sep 10, 20268-K0001104659-26-106705
Sep 1, 202640001104659-26-104404
Sep 1, 202640001104659-26-104402
Sep 1, 202640001104659-26-104405
Sep 1, 202640001104659-26-104403
Aug 28, 202640001104659-26-103374
Aug 28, 202640001104659-26-103376
Aug 28, 20268-K0001104659-26-102917
Aug 20, 20268-K0001104659-26-099239
Aug 14, 20268-K0001104659-26-097094
Aug 14, 202610-Q0001104659-26-097064
Jul 16, 2026ARS0001104659-26-084081
Jul 16, 2026DEF 14A0001104659-26-084078
Jul 6, 2026PRE 14A0001104659-26-080828
Jun 23, 20268-K0001104659-26-076822
Jun 4, 20268-K0001104659-26-070501
Jun 2, 2026424B30001104659-26-069166
Jun 2, 2026SCHEDULE 13G0001104659-26-069556
May 15, 2026SCHEDULE 13G/A0000919574-26-003240
May 15, 2026SCHEDULE 13G/A0000935836-26-000279
May 15, 2026SCHEDULE 13G/A0001104659-26-062875
May 7, 202610-Q0001104659-26-056941
May 7, 20268-K0001104659-26-057140
Apr 29, 2026SCHEDULE 13G/A0001716774-26-000012